J&J Looks to Fend Off Challenges to Key Drugs, Consumer Products

(Bloomberg) -- Johnson & Johnson posted weaker-than-expected sales in the final quarter of 2019, raising the stakes for the health-care conglomerate as it banks on new cancer and immunology drugs t...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.